tirzepatide and abdominal pain Should a patient experiencing while on Mounjaro (tirzepatide) stop the medication? Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic

Patients are encouraged to report any suspected side effects to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

doi: 10.3389/fgene.2022.839154 Received 19 December 2021 Accepted 18 February 2022 Published 13 June 2022 Volume 13 - 2022 Edited by Maritha J Kotze, Stellenbosch University, South Africa Reviewed by Sirimas Kanjanawart, Khon Kaen University, Thailand Chonlaphat Sukasem, Mahidol University, Thailand Updates Copyright 2022 Ferdiana, Fachiroh, Oktarina, Irwanto, Mahendra, Febriana and Soebono

these citations support the educational context only

Co-escalate slowly

Sermorelin may cause mild injection site reactions or temporary fatigue early in treatment

GHK-Cu Nasal Spray 50mg delivers fast absorption and a subtle onset to support skin repair, tissue recovery, and immune function from within